Literature DB >> 10691907

Early B cell defects.

H B Gaspar1, M E Conley.   

Abstract

Mesh：

Year:  2000        PMID： 10691907      PMCID： PMC1905597          DOI： 10.1046/j.1365-2249.2000.01192.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  82 in total

1.  Phosphorylation of two regulatory tyrosine residues in the activation of Bruton's tyrosine kinase via alternative receptors.

Authors:  M I Wahl; A C Fluckiger; R M Kato; H Park; O N Witte; D J Rawlings
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

2.  Impaired Ca2+ mobilization by X-linked agammaglobulinaemia (XLA) B cells in response to ligation of the B cell receptor (BCR).

Authors:  H C Genevier; R E Callard
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

3.  Constitutive membrane association potentiates activation of Bruton tyrosine kinase.

Authors:  T Li; D J Rawlings; H Park; R M Kato; O N Witte; A B Satterthwaite
Journal:  Oncogene       Date:  1997-09-18       Impact factor: 9.867

4.  Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia.

Authors:  M Hyvönen; M Saraste
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

Review 5.  Human intravenous immunoglobulin in primary and secondary antibody deficiencies.

Authors:  E R Stiehm
Journal:  Pediatr Infect Dis J       Date:  1997-07       Impact factor: 2.129

6.  Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family.

Authors:  S J Kornfeld; R N Haire; S J Strong; E N Brigino; H Tang; S S Sung; S M Fu; G W Litman
Journal:  J Allergy Clin Immunol       Date:  1997-11       Impact factor: 10.793

7.  A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.

Authors:  G G Klaus; M Holman; C Johnson-Léger; C Elgueta-Karstegl; C Atkins
Journal:  Eur J Immunol       Date:  1997-11       Impact factor: 5.532

8.  BTKbase, mutation database for X-linked agammaglobulinemia (XLA).

Authors:  M Vihinen; O Brandau; L J Brandén; S P Kwan; I Lappalainen; T Lester; J G Noordzij; H D Ochs; J Ollila; S M Pienaar; P Riikonen; B K Saha; C I Smith
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

9.  A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I.

Authors:  D A Grueneberg; R W Henry; A Brauer; C D Novina; V Cheriyath; A L Roy; M Gilman
Journal:  Genes Dev       Date:  1997-10-01       Impact factor: 11.361

10.  Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia.

Authors:  Y Minegishi; E Coustan-Smith; Y H Wang; M D Cooper; D Campana; M E Conley
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307
View more
  10 in total

1.  Introduction to immunodeficiency reviews

Authors: 
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  XLA patients with BTK splice-site mutations produce low levels of wild-type BTK transcripts.

Authors:  Jeroen G Noordzij; Sandra de Bruin-Versteeg; Nico G Hartwig; Corry M R Weemaes; Egbert J A Gerritsen; Eva Bernatowska; Stefaan van Lierde; Ronald de Groot; Jacques J M van Dongen
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

3.  B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans.

Authors:  Klaus Warnatz; Ulrich Salzer; Marta Rizzi; Beate Fischer; Sylvia Gutenberger; Joachim Böhm; Anne-Kathrin Kienzler; Qiang Pan-Hammarström; Lennart Hammarström; Mirzokhid Rakhmanov; Michael Schlesier; Bodo Grimbacher; Hans-Hartmut Peter; Hermann Eibel
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-06       Impact factor: 11.205

Review 4.  [Classification and diagnosis of immunodeficiency syndromes].

Authors:  K Warnatz; H-H Peter
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

5.  Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.

Authors:  R Pérez de Diego; E López-Granados; J Rivera; A Ferreira; G Fontán; J Bravo; M C García Rodríguez; S Bolland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

6.  Response to mRNA COVID-19 vaccination in three XLA patients.

Authors:  J D Squire; A Y Joshi
Journal:  Vaccine       Date:  2022-08-03       Impact factor: 4.169

7.  Optimization of immunoglobulin substitution therapy by a stochastic immune response model.

Authors:  Marc Thilo Figge
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

Review 8.  Agammaglobulinemia: from X-linked to Autosomal Forms of Disease.

Authors:  Melissa Cardenas-Morales; Vivian P Hernandez-Trujillo
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-09       Impact factor: 10.817

9.  Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.

Authors:  Natalie Burrows; Rachael J M Bashford-Rogers; Vijesh J Bhute; Ana Peñalver; John R Ferdinand; Benjamin J Stewart; Joscelin E G Smith; Mukta Deobagkar-Lele; Girolamo Giudice; Thomas M Connor; Akimichi Inaba; Laura Bergamaschi; Sam Smith; Maxine G B Tran; Evangelia Petsalaki; Paul A Lyons; Marion Espeli; Brian J P Huntly; Kenneth G C Smith; Richard J Cornall; Menna R Clatworthy; Patrick H Maxwell
Journal:  Nat Immunol       Date:  2020-08-31       Impact factor: 31.250

10.  X-linked Agammaglobulinemia Presenting with Multiviral Pneumonia.

Authors:  Yadis M Arroyo-Martinez; Michael Saindon; Jilmil S Raina
Journal:  Cureus       Date:  2020-04-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.